BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36442992)

  • 1. Transcriptomic and immunophenotypic profiling reveals molecular and immunological hallmarks of colorectal cancer tumourigenesis.
    Roelands J; van der Ploeg M; Ijsselsteijn ME; Dang H; Boonstra JJ; Hardwick JCH; Hawinkels LJAC; Morreau H; de Miranda NFCC
    Gut; 2023 Jul; 72(7):1326-1339. PubMed ID: 36442992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenoma to carcinoma: A portrait of molecular and immunological profiles of colorectal sporadic tumors.
    Elsayed I; Li L; Sheahan K; Moran B; Bakheit S; Wang X
    Int Immunopharmacol; 2021 Nov; 100():108168. PubMed ID: 34562842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Spatial Organization of Suppressive Myeloid Cells and Effector T Cells in Colorectal Cancer-A Potential Tool for Discovering Prognostic Biomarkers in Clinical Research.
    Zwing N; Failmezger H; Ooi CH; Hibar DP; Cañamero M; Gomes B; Gaire F; Korski K
    Front Immunol; 2020; 11():550250. PubMed ID: 33193316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPOCK1 and POSTN are valuable prognostic biomarkers and correlate with tumor immune infiltrates in colorectal cancer.
    Gan C; Li M; Lu Y; Peng G; Li W; Wang H; Peng Y; Hu Q; Wei W; Wang F; Liu L; Zhao Q
    BMC Gastroenterol; 2023 Jan; 23(1):4. PubMed ID: 36611136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive transcriptome profiling of Taiwanese colorectal cancer implicates an ethnic basis for pathogenesis.
    Wu SM; Tsai WS; Chiang SF; Lai YH; Ma CP; Wang JH; Lin J; Lu PS; Yang CY; Tan BC; Liu H
    Sci Rep; 2020 Mar; 10(1):4526. PubMed ID: 32161294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of Genome Alterations in Crohn's Disease-Associated Colorectal Carcinogenesis.
    Hirsch D; Wangsa D; Zhu YJ; Hu Y; Edelman DC; Meltzer PS; Heselmeyer-Haddad K; Ott C; Kienle P; Galata C; Horisberger K; Ried T; Gaiser T
    Clin Cancer Res; 2018 Oct; 24(20):4997-5011. PubMed ID: 29967250
    [No Abstract]   [Full Text] [Related]  

  • 7. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
    Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
    Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ap-2α/Elk-1 axis regulates Sirpα-dependent tumor phagocytosis by tumor-associated macrophages in colorectal cancer.
    Wang X; Luo X; Chen C; Tang Y; Li L; Mo B; Liang H; Yu S
    Signal Transduct Target Ther; 2020 Apr; 5(1):35. PubMed ID: 32296015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Genes Related to Clinicopathological Characteristics and Prognosis of Patients with Colorectal Cancer.
    Gao X; Yang J
    DNA Cell Biol; 2020 Apr; 39(4):690-699. PubMed ID: 32027181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
    Yue Y; Zhang Q; Sun Z
    Front Immunol; 2021; 12():758040. PubMed ID: 35140706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The actin-cytoskeleton pathway and its potential role in inflammatory bowel disease-associated human colorectal cancer.
    Kanaan Z; Qadan M; Eichenberger MR; Galandiuk S
    Genet Test Mol Biomarkers; 2010 Jun; 14(3):347-53. PubMed ID: 20406101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up.
    Bigagli E; De Filippo C; Castagnini C; Toti S; Acquadro F; Giudici F; Fazi M; Dolara P; Messerini L; Tonelli F; Luceri C
    Cell Oncol (Dordr); 2016 Dec; 39(6):545-558. PubMed ID: 27709558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy.
    Mini E; Lapucci A; Perrone G; D'Aurizio R; Napoli C; Brugia M; Landini I; Tassi R; Picariello L; Simi L; Mancini I; Messerini L; Magi A; Pinzani P; Mazzei T; Tonelli F; Nobili S
    Int J Cancer; 2019 Nov; 145(9):2580-2593. PubMed ID: 30973654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
    Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
    Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell genomic profile-based analysis of tissue differentiation in colorectal cancer.
    Jiang H; Zhang H; Zhang X
    Sci China Life Sci; 2021 Aug; 64(8):1311-1325. PubMed ID: 33141303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated stroma reveals prognostic biomarkers and novel insights into the tumour microenvironment of colorectal cancer and colorectal liver metastases.
    Brown KM; Xue A; Smith RC; Samra JS; Gill AJ; Hugh TJ
    Cancer Med; 2022 Jan; 11(2):492-506. PubMed ID: 34874125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling.
    de Wit M; Kant H; Piersma SR; Pham TV; Mongera S; van Berkel MP; Boven E; Pontén F; Meijer GA; Jimenez CR; Fijneman RJ
    J Proteomics; 2014 Mar; 99():26-39. PubMed ID: 24418523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential gene expression of tumor-infiltrating CD33
    Toor SM; Taha RZ; Sasidharan Nair V; Saleh R; Murshed K; Abu Nada M; Elkord E
    Cancer Immunol Immunother; 2021 Mar; 70(3):803-815. PubMed ID: 33000418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity.
    Wang J; Mouradov D; Wang X; Jorissen RN; Chambers MC; Zimmerman LJ; Vasaikar S; Love CG; Li S; Lowes K; Leuchowius KJ; Jousset H; Weinstock J; Yau C; Mariadason J; Shi Z; Ban Y; Chen X; Coffey RJC; Slebos RJC; Burgess AW; Liebler DC; Zhang B; Sieber OM
    Gastroenterology; 2017 Oct; 153(4):1082-1095. PubMed ID: 28625833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.